301 related articles for article (PubMed ID: 27922185)
1. Relaxin family peptides: structure-activity relationship studies.
Patil NA; Rosengren KJ; Separovic F; Wade JD; Bathgate RAD; Hossain MA
Br J Pharmacol; 2017 May; 174(10):950-961. PubMed ID: 27922185
[TBL] [Abstract][Full Text] [Related]
2. Relaxin-like peptides in male reproduction - a human perspective.
Ivell R; Agoulnik AI; Anand-Ivell R
Br J Pharmacol; 2017 May; 174(10):990-1001. PubMed ID: 27933606
[TBL] [Abstract][Full Text] [Related]
3. Recent progress in the understanding of relaxin family peptides and their receptors.
Summers RJ
Br J Pharmacol; 2017 May; 174(10):915-920. PubMed ID: 28447360
[TBL] [Abstract][Full Text] [Related]
4. Signal transduction pathways activated by insulin-like peptide 5 at the relaxin family peptide RXFP4 receptor.
Ang SY; Hutchinson DS; Patil N; Evans BA; Bathgate RAD; Halls ML; Hossain MA; Summers RJ; Kocan M
Br J Pharmacol; 2017 May; 174(10):1077-1089. PubMed ID: 27243554
[TBL] [Abstract][Full Text] [Related]
5. Structural commonality of C1q TNF-related proteins and their potential to activate relaxin/insulin-like family peptide receptor 1 signalling pathways in cancer cells.
Klonisch T; Glogowska A; Thanasupawat T; Burg M; Krcek J; Pitz M; Jaggupilli A; Chelikani P; Wong GW; Hombach-Klonisch S
Br J Pharmacol; 2017 May; 174(10):1025-1033. PubMed ID: 27443788
[TBL] [Abstract][Full Text] [Related]
6. Relaxin and insulin-like peptide 3 in the musculoskeletal system: from bench to bedside.
Ferlin A; De Toni L; Sandri M; Foresta C
Br J Pharmacol; 2017 May; 174(10):1015-1024. PubMed ID: 27059798
[TBL] [Abstract][Full Text] [Related]
7. The A-chain of human relaxin family peptides has distinct roles in the binding and activation of the different relaxin family peptide receptors.
Hossain MA; Rosengren KJ; Haugaard-Jönsson LM; Zhang S; Layfield S; Ferraro T; Daly NL; Tregear GW; Wade JD; Bathgate RA
J Biol Chem; 2008 Jun; 283(25):17287-97. PubMed ID: 18434306
[TBL] [Abstract][Full Text] [Related]
8. Synthetic non-peptide low molecular weight agonists of the relaxin receptor 1.
Agoulnik AI; Agoulnik IU; Hu X; Marugan J
Br J Pharmacol; 2017 May; 174(10):977-989. PubMed ID: 27771940
[TBL] [Abstract][Full Text] [Related]
9. Single chain peptide agonists of relaxin receptors.
Praveen P; Kocan M; Valkovic A; Bathgate R; Hossain MA
Mol Cell Endocrinol; 2019 May; 487():34-39. PubMed ID: 30641102
[TBL] [Abstract][Full Text] [Related]
10. The actions of relaxin on the human cardiovascular system.
Sarwar M; Du XJ; Dschietzig TB; Summers RJ
Br J Pharmacol; 2017 May; 174(10):933-949. PubMed ID: 27239943
[TBL] [Abstract][Full Text] [Related]
11. Serelaxin in clinical development: past, present and future.
Unemori E
Br J Pharmacol; 2017 May; 174(10):921-932. PubMed ID: 28009437
[TBL] [Abstract][Full Text] [Related]
12. Challenges in the design of insulin and relaxin/insulin-like peptide mimetics.
Hossain MA; Bathgate RAD
Bioorg Med Chem; 2018 Jun; 26(10):2827-2841. PubMed ID: 28988628
[TBL] [Abstract][Full Text] [Related]
13. Distribution, physiology and pharmacology of relaxin-3/RXFP3 systems in brain.
Ma S; Smith CM; Blasiak A; Gundlach AL
Br J Pharmacol; 2017 May; 174(10):1034-1048. PubMed ID: 27774604
[TBL] [Abstract][Full Text] [Related]
14. Structure of the R3/I5 chimeric relaxin peptide, a selective GPCR135 and GPCR142 agonist.
Haugaard-Jönsson LM; Hossain MA; Daly NL; Bathgate RA; Wade JD; Craik DJ; Rosengren KJ
J Biol Chem; 2008 Aug; 283(35):23811-8. PubMed ID: 18577524
[TBL] [Abstract][Full Text] [Related]
15. Vascular actions of relaxin: nitric oxide and beyond.
Leo CH; Jelinic M; Ng HH; Marshall SA; Novak J; Tare M; Conrad KP; Parry LJ
Br J Pharmacol; 2017 May; 174(10):1002-1014. PubMed ID: 27590257
[TBL] [Abstract][Full Text] [Related]
16. Structure and activity in the relaxin family of peptides.
Tregear GW; Bathgate RA; Hossain MA; Lin F; Zhang S; Shabanpoor F; Scott DJ; Ma S; Gundlach AL; Samuel CS; Wade JD
Ann N Y Acad Sci; 2009 Apr; 1160():5-10. PubMed ID: 19416150
[TBL] [Abstract][Full Text] [Related]
17. Structure of human insulin-like peptide 5 and characterization of conserved hydrogen bonds and electrostatic interactions within the relaxin framework.
Haugaard-Jönsson LM; Hossain MA; Daly NL; Craik DJ; Wade JD; Rosengren KJ
Biochem J; 2009 May; 419(3):619-27. PubMed ID: 19178384
[TBL] [Abstract][Full Text] [Related]
18. Structural properties of relaxin chimeras.
Haugaard-Jönsson LM; Hossain MA; Daly NL; Bathgate RA; Wade JD; Craik DJ; Rosengren KJ
Ann N Y Acad Sci; 2009 Apr; 1160():27-30. PubMed ID: 19416154
[TBL] [Abstract][Full Text] [Related]
19. Relaxin family peptides and their receptors.
Bathgate RA; Halls ML; van der Westhuizen ET; Callander GE; Kocan M; Summers RJ
Physiol Rev; 2013 Jan; 93(1):405-80. PubMed ID: 23303914
[TBL] [Abstract][Full Text] [Related]
20. International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides.
Halls ML; Bathgate RA; Sutton SW; Dschietzig TB; Summers RJ
Pharmacol Rev; 2015; 67(2):389-440. PubMed ID: 25761609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
